STTR Grant Helps Zen-Bio, LSU’s Pennington To ID Metabolic Disease Drug Candidates | GenomeWeb
Contract research organization Zen-Bio and the Pennington Biomedical Research Center of the Louisiana State University system have been awarded a one-year, approximately $229,000 Phase I Small Business Technology Transfer grant to look for natural compounds to prevent and treat metabolic disease and obesity.
The collaboration will use a library of natural botanical extracts developed by PBRC’s Botanical Research Center, which is a collaboration between PBRC and New Jersey’s Rutgers University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.